These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 21620368)
1. [Protein C deficiency in black African with venous thromboembolism in Cotonou, Benin]. Houénassi DM; Bigot A; Tchabi Y; Vehounkpé-Sacca J; Akindes-Dossou Yovo R; Gbaguidi L; d'Almeida-Massougbodji M; Agboton H Ann Cardiol Angeiol (Paris); 2013 Feb; 62(1):8-11. PubMed ID: 21620368 [TBL] [Abstract][Full Text] [Related]
2. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194 [TBL] [Abstract][Full Text] [Related]
3. Prevention of venous thromboembolism among inpatients at Cotonou teaching hospital, Benin. Martin Houénassi D; Tchabi Y; Akindès-Dossou Yovo R; Vehounkpe-Sacca J; Lawson M; Hans Moevi A; Zannou M; Amoussouguenou D; Gounongbe M; Abode A; Dossou F; Adjien C; Sagbohan V; Gnimassou J; Djrolo F; Hodonou R; Houngbe F; Avode G; Latoundji S; Desouza J; Padonou N; Bagnan K; Akpo C; Odoulami H; Zohoun I; d'Almeida-Massougbodji M; Agboton H Arch Cardiovasc Dis; 2009 Jan; 102(1):5-9. PubMed ID: 19233104 [TBL] [Abstract][Full Text] [Related]
4. Venous Thromboembolism in Children: From Diagnosis to Management. Lassandro G; Palmieri VV; Palladino V; Amoruso A; Faienza MF; Giordano P Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32664502 [TBL] [Abstract][Full Text] [Related]
5. Genetic Risk Factors in Venous Thromboembolism. Hotoleanu C Adv Exp Med Biol; 2017; 906():253-272. PubMed ID: 27638626 [TBL] [Abstract][Full Text] [Related]
6. VTE recurrence in patients with inherited deficiencies of natural anticoagulants. Dentali F; Gianni M Thromb Haemost; 2009 Jan; 101(1):5-6. PubMed ID: 19132180 [No Abstract] [Full Text] [Related]
7. Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study). Rouzaud D; Alexandra JF; Chauchard M; Delon M; Dossier A; Chauveheid MP; Perozziello A; Papo T; Sacre K Thromb Res; 2016 Aug; 144():116-8. PubMed ID: 27322086 [No Abstract] [Full Text] [Related]
9. Prospective study of circulating factor XI and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Folsom AR; Tang W; Roetker NS; Heckbert SR; Cushman M; Pankow JS Am J Hematol; 2015 Nov; 90(11):1047-51. PubMed ID: 26260105 [TBL] [Abstract][Full Text] [Related]
10. Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms. Bryk AH; Wypasek E; Plens K; Awsiuk M; Undas A Vascul Pharmacol; 2018 Jul; 106():22-27. PubMed ID: 29432897 [TBL] [Abstract][Full Text] [Related]
11. Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists. Di Nisio M; Ageno W; Rutjes AW; Pap AF; Büller HR Thromb Haemost; 2016 Jan; 115(2):424-32. PubMed ID: 26511068 [TBL] [Abstract][Full Text] [Related]
12. Deficiency of antithrombin and protein C gene in 202 Chinese venous thromboembolism patients. Gu Y; Shen W; Zhang L; Zhang J; Ying C Int J Lab Hematol; 2014 Apr; 36(2):151-5. PubMed ID: 24028705 [TBL] [Abstract][Full Text] [Related]
13. [Cutaneous necrosis at the initiation of antivitamin K treatment disclosing hereditary protein C deficiency]. Piffoux M; Tcherakian F; Tcherakian S; Horellou MH Rev Pneumol Clin; 1990; 46(3):125-7. PubMed ID: 2237146 [TBL] [Abstract][Full Text] [Related]
14. Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence: a post-hoc analysis of the PROLONG study. Legnani C; Palareti G; Cosmi B; Cini M; Tosetto A; Tripodi A; Haematologica; 2008 Jun; 93(6):900-7. PubMed ID: 18443269 [TBL] [Abstract][Full Text] [Related]
15. Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysis. Bleker SM; Brekelmans MPA; Eerenberg ES; Cohen AT; Middeldorp S; Raskob G; Büller HR Thromb Haemost; 2017 Oct; 117(10):1944-1951. PubMed ID: 28816341 [TBL] [Abstract][Full Text] [Related]
17. Extended treatment with non-vitamin K antagonist oral anticoagulants versus low-molecular-weight heparins in cancer patients following venous thromboembolism. A pilot study. Stepien K; Nowak K; Zalewski J; Pac A; Undas A Vascul Pharmacol; 2019 Sep; 120():106567. PubMed ID: 31158568 [TBL] [Abstract][Full Text] [Related]
18. [Skin necrosis during long-term fluindione treatment revealing protein C deficiency]. Merklen-Djafri C; Mazurier I; Samama MM; Alhenc-Gelas M; Tortel MC; Cribier B; Roth B; Batard ML Ann Dermatol Venereol; 2012 Mar; 139(3):199-203. PubMed ID: 22401685 [TBL] [Abstract][Full Text] [Related]
19. [Venous thromboembolism in patients with HIV: A case series]. Franco Moreno AI; de Ancos Aracil CL; Cabello Clotet N; San Martín López JV Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):216-7. PubMed ID: 22365182 [No Abstract] [Full Text] [Related]
20. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants. Legnani C; Martinelli I; Palareti G; Ciavarella A; Poli D; Ageno W; Testa S; Mastroiacovo D; Ciammaichella M; Bucherini E; Mumoli N; Cosmi B PLoS One; 2019; 14(7):e0219751. PubMed ID: 31310608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]